Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery

被引:1209
作者
Gold, Larry [1 ,2 ]
Ayers, Deborah [1 ]
Bertino, Jennifer [1 ]
Bock, Christopher [1 ]
Bock, Ashley [1 ]
Brody, Edward N. [1 ]
Carter, Jeff [1 ]
Dalby, Andrew B. [1 ]
Eaton, Bruce E. [5 ]
Fitzwater, Tim [1 ]
Flather, Dylan [1 ]
Forbes, Ashley [1 ]
Foreman, Trudi [1 ]
Fowler, Cate [1 ]
Gawande, Bharat [1 ]
Goss, Meredith [1 ]
Gunn, Magda [1 ]
Gupta, Shashi [1 ]
Halladay, Dennis [1 ]
Heil, Jim [1 ]
Heilig, Joe [1 ]
Hicke, Brian [1 ]
Husar, Gregory [1 ]
Janjic, Nebojsa [1 ]
Jarvis, Thale [1 ]
Jennings, Susan [1 ]
Katilius, Evaldas [1 ]
Keeney, Tracy R. [1 ]
Kim, Nancy [1 ]
Koch, Tad H. [5 ]
Kraemer, Stephan [1 ]
Kroiss, Luke [1 ]
Le, Ngan [1 ]
Levine, Daniel [3 ,4 ]
Lindsey, Wes [1 ]
Lollo, Bridget [1 ]
Mayfield, Wes [1 ]
Mehan, Mike [1 ]
Mehler, Robert [1 ]
Nelson, Sally K. [1 ]
Nelson, Michele [1 ]
Nieuwlandt, Dan [1 ]
Nikrad, Malti [1 ]
Ochsner, Urs [1 ]
Ostroff, Rachel M. [1 ]
Otis, Matt [1 ]
Parker, Thomas [3 ,4 ]
Pietrasiewicz, Steve [1 ]
Resnicow, Daniel I. [1 ]
Rohloff, John [1 ]
机构
[1] SomaLogic, Boulder, CO USA
[2] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO USA
[3] Cornell Univ, Rogosin Inst, New York, NY USA
[4] Cornell Univ, Weill Med Coll, New York, NY USA
[5] Univ Colorado, Dept Chem & Biochem, Boulder, CO USA
来源
PLOS ONE | 2010年 / 5卷 / 12期
关键词
IN-VITRO SELECTION; SYSTEMATIC EVOLUTION; STATISTICAL-MODEL; KIDNEY-FUNCTION; RNA LIGANDS; PROTEINS; OLIGONUCLEOTIDES; DIAGNOSTICS; PEGAPTANIB; BINDING;
D O I
10.1371/journal.pone.0015004
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. Methodology/Principal Findings We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 mu L of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (similar to 100 fM-1 mu M), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. Conclusions/Significance We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
引用
收藏
页数:17
相关论文
共 46 条
[1]  
20090004667 US, 2009, ZICHI D
[2]   Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma [J].
Addona, Terri A. ;
Abbatiello, Susan E. ;
Schilling, Birgit ;
Skates, Steven J. ;
Mani, D. R. ;
Bunk, David M. ;
Spiegelman, Clifford H. ;
Zimmerman, Lisa J. ;
Ham, Amy-Joan L. ;
Keshishian, Hasmik ;
Hall, Steven C. ;
Allen, Simon ;
Blackman, Ronald K. ;
Borchers, Christoph H. ;
Buck, Charles ;
Cardasis, Helene L. ;
Cusack, Michael P. ;
Dodder, Nathan G. ;
Gibson, Bradford W. ;
Held, Jason M. ;
Hiltke, Tara ;
Jackson, Angela ;
Johansen, Eric B. ;
Kinsinger, Christopher R. ;
Li, Jing ;
Mesri, Mehdi ;
Neubert, Thomas A. ;
Niles, Richard K. ;
Pulsipher, Trenton C. ;
Ransohoff, David ;
Rodriguez, Henry ;
Rudnick, Paul A. ;
Smith, Derek ;
Tabb, David L. ;
Tegeler, Tony J. ;
Variyath, Asokan M. ;
Vega-Montoto, Lorenzo J. ;
Wahlander, Asa ;
Waldemarson, Sofia ;
Wang, Mu ;
Whiteaker, Jeffrey R. ;
Zhao, Lei ;
Anderson, N. Leigh ;
Fisher, Susan J. ;
Liebler, Daniel C. ;
Paulovich, Amanda G. ;
Regnier, Fred E. ;
Tempst, Paul ;
Carr, Steven A. .
NATURE BIOTECHNOLOGY, 2009, 27 (07) :633-U85
[3]  
Aebersold R, 2009, NAT METHODS, V6, P411, DOI [10.1038/nmeth.f.255, 10.1038/NMETH.F.255]
[4]  
Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]
[5]   Engineering novel binding proteins from nonimmunoglobulin domains [J].
Binz, HK ;
Amstutz, P ;
Plückthun, A .
NATURE BIOTECHNOLOGY, 2005, 23 (10) :1257-1268
[6]   High-throughput proteomics using antibody microarrays: an update [J].
Borrebaeck, Carl A. K. ;
Wingren, Christer .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2007, 7 (05) :673-686
[7]  
Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5
[8]   The Emerging Role of Biomarkers in Diabetic and Hypertensive Chronic Kidney Disease [J].
Chaudhary, Kunal ;
Phadke, Gautam ;
Nistala, Ravi ;
Weidmeyer, Charles E. ;
McFarlane, Samy I. ;
Whaley-Connell, Adam .
CURRENT DIABETES REPORTS, 2010, 10 (01) :37-42
[9]   A method for reducing the time required to match protein sequences with tandem mass spectra [J].
Craig, R ;
Beavis, RC .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2003, 17 (20) :2310-2316
[10]   NEW URIDINE DERIVATIVES FOR SYSTEMATIC EVOLUTION OF RNA LIGANDS BY EXPONENTIAL ENRICHMENT [J].
DEWEY, TM ;
MUNDT, AA ;
CROUCH, GJ ;
ZYZNIEWSKI, MC ;
EATON, BE .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (32) :8474-8475